AMRI will cease Discovery and Development Services (DDS) operations at its Syracuse, NY site by the end of June 2014. The company will transition these activities to other sites as part of an effort to consolidate facility resources and reduce costs.   AMRI’s Syracuse site provides chemical process R&D, custom chemical synthesis and scale-up of pharmaceuticals intermediates and final products. As part of the transition, Syracuse DDS capabilities and some employees will be transferred t...